🇺🇸 FDA

Company profile · Sponsor

KIORA

KIORA PHARMACEUTICALS INC

KPRX · NYSE pharma ENCINITAS, CA, USA
Pipeline
5
Drugs
0
Patents
4

Quick answer

KIORA (KPRX) is a pharma company. headquartered in ENCINITAS, CA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 4 patents to this profile..

Company facts

Ticker KPRX
Exchange NYSE
Company type pharma
Headquarters ENCINITAS, CA, USA
SEC CIK 0001372514

Pipeline (5)

Search pipeline →

  1. 100 μg KIO-301

    KIORA

    Retinitis Pigmentosa

    phase 2 small molecule active

    1 trial

  2. KIO-101

    KIORA

    Dry Eye Disease

    phase 2 small molecule terminated

    1 trial

  3. KIO-104

    KIORA

    Macular Edema

    phase 2 small molecule active

    1 trial

  4. KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75% (CMHA-S)

    KIORA

    Persistent Corneal Epithelial Defect

    phase 2 small molecule completed

    1 trial

  5. KIO-301

    KIORA

    Retinitis Pigmentosa

    phase 2 small molecule completed

    1 trial

Patents (4)

Search patents →

  1. US 12364680

    Compounds for treating ophthalmic diseases and disorders

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12209073

    Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor

    Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11730716

    Compounds for treating ophthalmic diseases and disorders

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11376214

    Compositions and methods for treatment of ocular diseases

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is KIORA?

KIORA (KPRX) is a pharma company. headquartered in ENCINITAS, CA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 4 patents to this profile..

What pipeline programs does KIORA sponsor?

We track 5 ClinicalTrials.gov-linked programs for KIORA, including 100 μg KIO-301 and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does KIORA company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.